<!doctype html>
<html lang="en">

<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">

  <link
    crossorigin="anonymous"
    href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap/5.1.3/css/bootstrap.min.css"
    integrity="sha512-GQGU0fMMi238uA+a/bdWJfpUGKUkBdgfFdgBm72SUQ6BeyWjoY/ton0tEjH+OSH9iP4Dfh+7HM0I9f5eR0L/4w=="
    referrerpolicy="no-referrer"
    rel="stylesheet"
  />
  <link rel="stylesheet" href="./static/css/oxford.css">
  <link rel="stylesheet" href="./static/css/outliers.css">

  <title>Static outliers for NHS Northamptonshire CCG</title>
</head>
<body>
    <div class="bg-dark">
      <div class="container d-flex justify-content-center">
        <a class="visually-hidden-focusable text-white p-2" href="#content">Skip to main content</a>
      </div>
    </div>

    <header>
      <nav class="navbar navbar-expand-lg navbar-dark bg-dark bg-oxford">
        <div class="container">
          <a class="navbar-brand" href="../index.html">OpenPrescribing outlier detection</a>
        </div>
      </nav>
    </header>

    <main id="content">
      <div class="bg-oxford-50 mb-4">
        <div class="container pt-5 pb-4">
          <div class="row">
            <div class="col-12">
              <h1 class="display-5 fw-bold lh-1">Static outliers for NHS Northamptonshire CCG</h1>
            </div>
            <div class="col-lg-8 col-md-9 col-12 pt-4 fs-5">
              <p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
                explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to identify unusual prescribing and collect feedback on this prescribing to inform development of new tools to support
                prescribers and organisations to audit and review prescribing.</p>
              <p>This report has been developed to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. We calculate the number of prescriptions for each chemical
                  in the <a href="https://www.thedatalab.org/blog/161/prescribing-data-bnf-codes">BNF coding system</a> using the BNF subparagraph as a denominator, for prescriptions dispensed between April 2021 and August 2021. We then calculate the
                  mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs/STPs. From this we can calculate the “z-score”, which is a measure of how many standard deviations a given practice/CCG/PCN/STP is from the
                  population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier for prescribing lower than its peers.
              </p>
              <p>It is important to remember that this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where
                  it might not. Our full analytical method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a>.
              </p>
              <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=ccg+78H">survey</a>            or emailing us at <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can
                  send short or detailed feedback.
              </p>
            </div>
          </div>
        </div>
      </div>
    </main>

    <section aria-labelledby="higherHeading">
      <div class="container">
        <h2 class="pb-3" id="higherHeading">Prescribing where NHS Northamptonshire CCG is higher than most</h2>
      </div>
      <div class="container px-lg-4 mb-4">
        <div class="table-responsive">
          <table border="1" class="dataframe table table table-sm table-bordered" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Standard Deviation">std</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr class="low_number row_1">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0408010K0&amp;denomIds=4.8.1&amp;selectedTab=summary">Mesuximide</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_0_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>1</td>
      <td>Control of epilepsy</td>
      <td>167273</td>
      <td>0.00</td>
      <td>0.0</td>
      <td>0.00</td>
      <td>10.20</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_MJ3aGZmiBmiHptHRkAKUG9ySCCLDVfox"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_MJ3aGZmiBmiHptHRkAKUG9ySCCLDVfox" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0408010K0AAAAAA&amp;denomIds=4.8.1&amp;selectedTab=summary" target="_blank">Mesuximide 300mg capsules : 1</a></li></ul></td></tr><tr class="row_2">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0408010AA&amp;denomIds=4.8.1&amp;selectedTab=summary">Felbamate</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_1_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>6</td>
      <td>Control of epilepsy</td>
      <td>167273</td>
      <td>0.00</td>
      <td>0.0</td>
      <td>0.00</td>
      <td>7.66</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_BDXWh5xKkS0CndDWVgwEC5FsDUiRUi09"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_BDXWh5xKkS0CndDWVgwEC5FsDUiRUi09" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0408010AAAAABAB&amp;denomIds=4.8.1&amp;selectedTab=summary" target="_blank">Felbamate 600mg tablets : 6</a></li></ul></td></tr><tr class="row_3">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0601023AR&amp;denomIds=6.1.2&amp;selectedTab=summary">Empagliflozin/metformin</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_2_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>4574</td>
      <td>Other antidiabetic drugs</td>
      <td>82853</td>
      <td>0.06</td>
      <td>0.0</td>
      <td>0.01</td>
      <td>6.52</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_DDvazlAU3altYVq1jihGFBV8oKOuxdZW"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_DDvazlAU3altYVq1jihGFBV8oKOuxdZW" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0601023ARAAAAAA&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Empagliflozin 5mg / Metformin 850mg tablets : 106</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0601023ARAAABAB&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Empagliflozin 5mg / Metformin 1g tablets : 1796</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0601023ARAAACAC&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Empagliflozin 12.5mg / Metformin 850mg tablets : 110</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0601023ARAAADAD&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Empagliflozin 12.5mg / Metformin 1g tablets : 2545</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0601023ARBBAAAA&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Synjardy 5mg/850mg tablets : 6</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0601023ARBBABAB&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Synjardy 5mg/1000mg tablets : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0601023ARBBADAD&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Synjardy 12.5mg/1000mg tablets : 6</a></li></ul></td></tr><tr class="row_4">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0601023AL&amp;denomIds=6.1.2&amp;selectedTab=summary">Dapagliflozin/metformin</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_3_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>1603</td>
      <td>Other antidiabetic drugs</td>
      <td>82853</td>
      <td>0.02</td>
      <td>0.0</td>
      <td>0.00</td>
      <td>5.12</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_iSYCJYYYjfHECIILYqIGXEoRcBcQURhU"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_iSYCJYYYjfHECIILYqIGXEoRcBcQURhU" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0601023ALAAAAAA&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Dapagliflozin 5mg / Metformin 850mg tablets : 66</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0601023ALAAABAB&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Dapagliflozin 5mg / Metformin 1g tablets : 1529</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0601023ALBBABAB&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Xigduo 5mg/1000mg tablets : 8</a></li></ul></td></tr><tr class="row_5">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=1001030AC&amp;denomIds=10.1.3&amp;selectedTab=summary">Baricitinib</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_4_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>9</td>
      <td>Rheumatic disease suppressant drugs</td>
      <td>22387</td>
      <td>0.00</td>
      <td>0.0</td>
      <td>0.00</td>
      <td>4.53</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_QhPLSpoIAuGpy9IQq5AgdYQHn4BKJAJN"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_QhPLSpoIAuGpy9IQq5AgdYQHn4BKJAJN" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=1001030ACAAAAAA&amp;denomIds=10.1.3&amp;selectedTab=summary" target="_blank">Baricitinib 4mg tablets : 9</a></li></ul></td></tr></tbody></table>
        </div>
      </div>
    </section>

    <section aria-labelledby="lowerHeading">
      <div class="container">
        <h2 class="pb-3" id="lowerHeading">Prescribing where NHS Northamptonshire CCG is lower than most</h2>
      </div>
      <div class="container px-lg-4 mb-4">
        <div class="table-responsive">
          <table border="1" class="dataframe table table table-sm table-bordered" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Standard Deviation">std</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr class="row_1">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=1307000M0&amp;denomIds=13.7&amp;selectedTab=summary">Salicylic acid</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_0_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>36</td>
      <td>Preparations for warts and calluses</td>
      <td>240</td>
      <td>0.15</td>
      <td>0.68</td>
      <td>0.15</td>
      <td>-3.50</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_YplUUsauGJMYjakopgLGAmRHW40IYlhk"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_YplUUsauGJMYjakopgLGAmRHW40IYlhk" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=1307000M0AAAEAE&amp;denomIds=13.7&amp;selectedTab=summary" target="_blank">Salicylic acid 50% ointment : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=1307000M0AAAVAV&amp;denomIds=13.7&amp;selectedTab=summary" target="_blank">Salicylic acid 12% / Lactic acid 4% gel : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=1307000M0AAAWAW&amp;denomIds=13.7&amp;selectedTab=summary" target="_blank">Salicylic acid 16.7% / Lactic acid 16.7% paint : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=1307000M0AABABA&amp;denomIds=13.7&amp;selectedTab=summary" target="_blank">Salicylic acid 26% solution : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=1307000M0AABMBM&amp;denomIds=13.7&amp;selectedTab=summary" target="_blank">Salicylic acid 26% gel : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=1307000M0AABYBY&amp;denomIds=13.7&amp;selectedTab=summary" target="_blank">Salicylic acid 16.7% / Lactic acid 15% paint : 12</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=1307000M0BFAAAE&amp;denomIds=13.7&amp;selectedTab=summary" target="_blank">Verrugon complete 50% ointment : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=1307000M0BJAAAV&amp;denomIds=13.7&amp;selectedTab=summary" target="_blank">Salatac gel : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=1307000M0BKABBY&amp;denomIds=13.7&amp;selectedTab=summary" target="_blank">Duofilm paint : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=1307000M0BXAAAV&amp;denomIds=13.7&amp;selectedTab=summary" target="_blank">Bazuka gel : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=1307000M0BXACAV&amp;denomIds=13.7&amp;selectedTab=summary" target="_blank">Bazuka Treatment gel : 1</a></li></ul></td></tr><tr class="row_2">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0106010E0&amp;denomIds=1.6.1&amp;selectedTab=summary">Ispaghula husk</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_1_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>7936</td>
      <td>Bulk-forming laxatives</td>
      <td>9051</td>
      <td>0.88</td>
      <td>0.96</td>
      <td>0.03</td>
      <td>-3.31</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_MlGJ4lJRieBGMCp6EKMIGAxlUAziGjXI"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_MlGJ4lJRieBGMCp6EKMIGAxlUAziGjXI" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0106010E0AAADAD&amp;denomIds=1.6.1&amp;selectedTab=summary" target="_blank">Ispaghula husk 3.5g efferv gran sach gluten free sugar free : 3201</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0106010E0AAATAT&amp;denomIds=1.6.1&amp;selectedTab=summary" target="_blank">Ispaghula husk 3.5g granules sachets gluten free : 80</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0106010E0BBAAAD&amp;denomIds=1.6.1&amp;selectedTab=summary" target="_blank">Fybogel 3.5g effervescent granules sachets plain SF : 681</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0106010E0BBABAD&amp;denomIds=1.6.1&amp;selectedTab=summary" target="_blank">Fybogel Orange 3.5g effervescent granules sachets SF : 3128</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0106010E0BBACAD&amp;denomIds=1.6.1&amp;selectedTab=summary" target="_blank">Fybogel Lemon 3.5g effervescent granules sachets SF : 616</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0106010E0BJAAAD&amp;denomIds=1.6.1&amp;selectedTab=summary" target="_blank">Ispagel Orange 3.5g effervescent granules sachets : 8</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0106010E0BKAAAD&amp;denomIds=1.6.1&amp;selectedTab=summary" target="_blank">Fybogel Hi-Fibre Orange 3.5g effervescent granules sachets : 180</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0106010E0BKABAD&amp;denomIds=1.6.1&amp;selectedTab=summary" target="_blank">Fybogel Hi-Fibre Lemon 3.5g effervescent granules sachets : 42</a></li></ul></td></tr><tr class="low_number row_3">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=1311040K0&amp;denomIds=13.11.4&amp;selectedTab=summary">Iodine compounds</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_2_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>3</td>
      <td>Chlorine and iodine</td>
      <td>5</td>
      <td>0.60</td>
      <td>0.96</td>
      <td>0.12</td>
      <td>-2.90</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_xTq1tVatdVrrUmqrUNCWW6GFYlk49V4v"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_xTq1tVatdVrrUmqrUNCWW6GFYlk49V4v" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=1311040K0AAATAT&amp;denomIds=13.11.4&amp;selectedTab=summary" target="_blank">Povidone-Iodine 10% antiseptic solution : 3</a></li></ul></td></tr><tr class="row_4">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0&amp;denomIds=9.6.4&amp;selectedTab=summary">Colecalciferol</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_3_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>99545</td>
      <td>Vitamin D</td>
      <td>105505</td>
      <td>0.94</td>
      <td>0.97</td>
      <td>0.01</td>
      <td>-2.71</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_KQEiUakovhBANIJkoxhejhhciyAIMQY1"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_KQEiUakovhBANIJkoxhejhhciyAIMQY1" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AAACAC&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 3,000unit tablets : 18</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AAANAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 800unit capsules : 3765</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AABFBF&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 600unit capsules : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AABGBG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 1,000unit tablets : 183</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AABHBH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 1,000unit capsules : 137</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AABIBI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit capsules : 234</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AABSBS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit / Calcium carbonate 1.5g tablets : 44</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AABTBT&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,000units/ml oral drops sugar free : 13</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AABUBU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 200unit / Calcium carbonate 1.25g chew tab : 190</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AABWBW&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit / Calcium carbonate 1.25g chew tab : 869</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AABXBX&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 440unit/Calcium carb 1.25g efferv gran sach : 60</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AABYBY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit / Calcium carbonate 1.5g chewable tab : 1954</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AABZBZ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 800unit/Calcium phosphate 3.1g oral pdr sach : 64</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AACBCB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit / Calcium carbonate 1.5g efferv tab : 385</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AACCCC&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit / Calcium carbonate 1.25g tablets : 16</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AACDCD&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 200unit / Calcium carbonate 750mg tablets : 392</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AACICI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400units/dose oral spray sugar free : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AACNCN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 5,000unit tablets : 9</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AACPCP&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,200unit tablets : 10</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AACQCQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 10,000unit tablets : 17</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AACRCR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 20,000unit tablets : 19</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AACSCS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 800unit tablets : 694</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AACVCV&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 40,000unit capsules : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AACYCY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 50,000unit tablets : 20</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AADBDB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,000unit tablets : 44</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AADFDF&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 3,200unit capsules : 121</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AADHDH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 25,000units/1ml soln ud amp sugar free : 86</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AADIDI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 880unit / Calcium carbonate 2.5g chew tab : 138</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AADKDK&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 25,000unit tablets : 8</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AADLDL&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 800unit / Calcium carbonate 2.5g chewable tab : 99</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AADNDN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 10,000units/ml oral drops sugar free : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AADPDP&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 10,000units/ml oral solution sugar free : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AADQDQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,400units/ml oral drops sugar free : 16</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AADRDR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 20,000unit capsules : 48</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AADTDT&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,740units/ml oral drops sugar free : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AADUDU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 50,000units/1ml soln ud amp sugar free : 53</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AAEAEA&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 5,000unit capsules : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AAEBEB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 1,000unit / Calcium carbonate 2.5g chew tab : 84</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AAEEEE&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 4,000unit tablets : 61</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AAEJEJ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 5,600unit capsules : 23</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AAEKEK&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 25,000unit capsules : 59</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AAELEL&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit tablets : 344</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AAEPEP&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 10,000units/5ml oral solution sugar free : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AAEQEQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 50,000unit capsules : 208</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AAERER&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit chewable tablets : 9</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AAETET&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400units/ml oral drops sugar free : 7</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0AAFGFG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 200units/drop oral drops : 9</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0BIAABI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 400unit capsules : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0BIABBH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 1,000unit capsules : 13</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0BIADDV&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 10,000unit capsules : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0BIAEDR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 20,000unit capsules : 6</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0BIAGBT&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 2,000units/ml liquid drops : 51</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0BIAICU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 2,000units/ml liquid : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0BKAABS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Accrete D3 tablets : 7364</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0BKABDI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Accrete D3 One a Day 1000mg/880unit chewable tablets : 312</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0BMAABG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Valupak Vitamin D3 1,000unit tablets : 29</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0BMABBH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Valupak Vitamin D3 1,000unit capsules : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0BNAABY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Adcal-D3 chewable tablets tutti frutti : 7075</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0BNABBY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Adcal-D3 Lemon chewable tablets : 1332</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0BNACCB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Adcal-D3 Dissolve 1500mg/400unit effervescent tablets : 1589</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0BNADCD&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Adcal-D3 750mg/200unit caplets : 13686</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0BPAABX&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Cacit D3 effervescent granules sachets : 71</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0BQAABW&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calceos 500mg/400unit chewable tablets : 1069</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0BRAABU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calcichew D3 chewable tablets : 471</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0BRABBW&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calcichew D3 Forte chewable tablets : 866</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0BRACCC&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calcichew D3 500mg/400unit caplets : 26</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0BRADDL&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calcichew D3 1000mg/800unit Once Daily chewable tablets : 69</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0BSAABZ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calfovit D3 oral powder sachets : 102</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0BUAABY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Natecal D3 600mg/400unit chewable tablets : 17</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0BWAABG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 1,000unit tablets : 12</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0BWABCQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 10,000unit tablets : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0BWACCR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 20,000unit tablets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0BWAEDB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 2,000unit tablets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0BWAFCN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 5,000unit tablets : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0BWAIBT&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 2,000units/ml oral drops : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0BWAJEL&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 400unit tablets : 6</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0BWAKCS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 800unit tablets : 35</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0BWALBI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 400unit capsules : 6</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0BWASEN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 3,000units/ml oral solution : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0BWAUAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 800unit capsules : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0BWAYEL&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 400unit Vegan tablets : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0BXAAAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Fultium-D3 800unit capsules : 3799</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0BXABDF&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Fultium-D3 3,200unit capsules : 220</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0BXACDR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Fultium-D3 20,000unit capsules : 11</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0BXADDT&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Fultium-D3 2,740units/ml oral drops : 7</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0BZAACI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">DLux 400 oral spray : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0CCAADS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 forte 3,000units/ml liquid : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0CGAADR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Hux D3 20,000unit capsules : 26</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0CHAAEL&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Aciferol D3 400unit tablets : 11</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0CHABBG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Aciferol D3 1,000unit tablets : 8</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0CHACCP&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Aciferol D3 2,200unit tablets : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0CHADAC&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Aciferol D3 3,000unit tablets : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0CHAFCQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Aciferol D3 10,000unit tablets : 63</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0CHAIEQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Aciferol D3 50,000unit capsules : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0CHAJDS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Aciferol D3 3,000units/ml liquid : 41</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0CHAKCU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Aciferol D3 2,000units/ml liquid : 7</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0CJAACS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Desunin 800unit tablets : 100</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0CJABEE&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Desunin 4,000unit tablets : 77</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0CVABBH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">OsteoCaps D3 1,000unit capsules : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0CWAABY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Evacal D3 1500mg/400unit chewable tablets : 41227</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0DBAACN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Vitamin D3 High Strength 5,000unit tablets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0DCABDD&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Vitamin D3 Lemon Melts 2,000unit tablets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0DDAADS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Kora LiquiD 3000units/ml oral solution : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0DFAADH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 25,000units/1ml oral solution : 1184</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0DFABDQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 2,400units/ml oral drops : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0DFACDU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 50,000units/1ml oral solution : 593</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0DFADAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 800unit capsules : 1686</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0DFAEBI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 400unit capsules : 38</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0DFAFEQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 50,000unit capsules : 1605</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0DFAGEK&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 25,000unit capsules : 398</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0DFAHEJ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 5,600unit capsules : 7</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0DGAADI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">TheiCal-D3 1000mg/880unit chewable tablets : 1296</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0DHAABG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Stexerol-D3 1,000unit tablets : 9</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0DIAADN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Thorens 10,000units/ml oral drops : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0906040G0DMAAEB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calci-D 1000mg/1,000unit chewable tablets : 2336</a></li></ul></td></tr><tr class="row_5">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0704020AA&amp;denomIds=7.4.2&amp;selectedTab=summary">Duloxetine hydrochloride</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_4_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>702</td>
      <td>Drugs for urinary frequency enuresis and incontinence</td>
      <td>42012</td>
      <td>0.02</td>
      <td>0.04</td>
      <td>0.01</td>
      <td>-2.55</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_8VFLXEVdHAAFVBRBHTVZIfDA0QUQYQZ"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_8VFLXEVdHAAFVBRBHTVZIfDA0QUQYQZ" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0704020AAAAAAAA&amp;denomIds=7.4.2&amp;selectedTab=summary" target="_blank">Duloxetine 20mg gastro-resistant capsules : 399</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0704020AAAAABAB&amp;denomIds=7.4.2&amp;selectedTab=summary" target="_blank">Duloxetine 40mg gastro-resistant capsules : 296</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=78H&amp;numIds=0704020AABBAAAA&amp;denomIds=7.4.2&amp;selectedTab=summary" target="_blank">Yentreve 20mg gastro-resistant capsules : 7</a></li></ul></td></tr></tbody></table>
        </div>
      </div>
    </section>

    <script
      crossorigin="anonymous"
      integrity="sha512-pax4MlgXjHEPfCwcJLQhigY7+N8rt6bVvWLFyUMuxShv170X53TRzGPmPkZmGBhk+jikR8WBM4yl7A9WMHHqvg=="
      referrerpolicy="no-referrer"
      src="https://cdnjs.cloudflare.com/ajax/libs/bootstrap/5.1.3/js/bootstrap.bundle.min.js"
    ></script>
    <script>
      var tooltipTriggerList = [].slice.call(
        document.querySelectorAll('[data-bs-toggle="tooltip"]')
      );
      var tooltipList = tooltipTriggerList.map(function (tooltipTriggerEl) {
        return new bootstrap.Tooltip(tooltipTriggerEl);
      });
    </script>
</body>

</html>